Effects of microplastics on chemo-resistance and tumorigenesis of colorectal cancer

Wen Pan1, Yueting Han1, Mingqing Zhang1

  • 1Tianjin Institute of Coloproctology,Tianjin Union Medical Center, The First Affiliated Hospital of Nankai University, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, 300121, China.

Insights

Microplastics (MPs) are found in human colorectal cancer (CRC) tissues, increasing CRC incidence and promoting chemoresistance by enhancing autophagy. Blocking MP intake may offer a novel clinical treatment approach for CRC.

Area of Science:

  • Environmental Science
  • Oncology
  • Gastroenterology

Background:

  • Microplastics (MPs) are pervasive environmental pollutants with known adverse health effects.
  • The specific role of MPs in tumor development, particularly colorectal cancer (CRC), and their impact on chemotherapy remains largely uninvestigated.
  • The gastrointestinal tract is a primary site for MP absorption, highlighting its relevance to CRC.

Purpose of the Study:

  • To investigate the presence of MPs in human CRC tissues.
  • To explore the effects of MPs on CRC incidence, progression, and chemoresistance.
  • To elucidate the underlying mechanisms by which MPs influence CRC, including autophagy and gut microbiota.

Main Methods:

  • Laser direct infrared chemical imaging system to detect MPs in human CRC tissues.
  • Animal models to assess the impact of MPs on CRC incidence and oxaliplatin resistance.
  • Analysis of autophagy pathways (mTOR) and gut microbiota composition in response to MP exposure.

Main Results:

  • MPs were detected in human CRC tissues for the first time.
  • MP exposure increased CRC incidence and promoted resistance to oxaliplatin in animal models.
  • MPs enhance autophagy via mTOR activation, disrupt gut flora, and promote intestinal inflammation, contributing to CRC onset and progression.

Conclusions:

  • Microplastic pollutants in CRC can mediate protective autophagy through the mTOR/ULK1 axis, contributing to chemoresistance.
  • MPs play a role in the onset and advancement of colorectal cancer.
  • Blocking MP intake presents a potential novel strategy for clinical precision treatment of CRC.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
1.9K